Interestingly, some authors have emphasized the fact that ADT used in metastatic PC to inhibit the androgen receptor (AR) activation, could promote a lineage plasticity with modifications in staining for prostate biomarkers [50]. This evidence concerns the gene AR and pachyonychia congenita.